{"id":"NCT01101035","sponsor":"Takeda","briefTitle":"Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)","officialTitle":"A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-04-23","primaryCompletion":"2017-05-15","completion":"2017-07-18","firstPosted":"2010-04-09","resultsPosted":"2018-06-14","lastUpdate":"2018-06-14"},"enrollment":6198,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cardiovascular Disease"],"interventions":[{"type":"DRUG","name":"Febuxostat","otherNames":["Uloric","TMX-67"]},{"type":"DRUG","name":"Allopurinol","otherNames":["Zyloprim","Allohexal","Allosig","Milurit","Alloril","Progout","Zyloric","Puricos","Zyrik 300","Aluron"]}],"arms":[{"label":"Febuxostat","type":"EXPERIMENTAL"},{"label":"Allopurinol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to see whether subjects with gout who receive febuxostat or allopurinol for up to 9 years have a higher rate of serious heart and blood vessel complications (major cardiovascular events).","primaryOutcome":{"measure":"Percentage of Participants With Primary Major Adverse Cardiovascular Events (MACE) Composite (75% Interim Analysis)","timeFrame":"Up to last dose of study drug (approximately 83 months)","effectByArm":[{"arm":"Febuxostat","deltaMin":8,"sd":null},{"arm":"Allopurinol","deltaMin":8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":203,"countries":["United States","Mexico"]},"refs":{"pmids":["22795277","29527974","35536764","21849262"],"seeAlso":["http://general.takedapharm.com/content/file.aspx?applicationcode=6C7C39D8-5D09-453B-BF30-696A4AB88E62&fileTypeCode=ULORICPI"]},"adverseEventsSummary":{"seriousAny":{"events":1046,"n":3098},"commonTop":["Diarrhoea","Arthralgia","Upper respiratory tract infection","Hypertension","Pain in extremity"]}}